Cn nhiu nghin cu hn a ra con s v liu dng l tng nhng a s cc nghin cu u khuyn co 1000mg mi ngy
I dont have any patients on a compounded GLP-1, but if I did, and they were taking a pretty high dose, there would be many factors we would discuss
52 This strategy has been applied in a phase 1/2a clinical trial (NCT04945018) conducted by the Fukuda group and HeartSeed/NovNordisk
The hormone-aware metabolic framework describes a structured sequence for metabolic intervention: stabilizing hormonal conditions first, calibrating GLP-1 dosing second, accelerating metabolic improvement through monitoring and titration, and preserving lean mass throughout the process
Canonically, this involves the decomposition of Sec by selenocysteine -lyase, producing selenide that is phosphorylated by selenophosphate synthetase 2 (SEPHS2) to generate selenophosphate for Sec-tRNA synthesis [186]